Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
42 participants
INTERVENTIONAL
2011-12-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pregabalin and Analgesia After Laparoscopic Cholecystectomy
NCT01321801
Venlafaxine for Postoperative Pain of Laparoscopic Cholecystectomy
NCT05884268
Duloxetine for Postoperative Pain of Laparoscopic Cholecystectomy
NCT05115123
Postoperative Intraperitoneal Pain Management Following Laparoscopic Cholecystectomy
NCT06281418
Analgesia in Laparoscopic Cholecystectomy
NCT01388946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
pregabalin 150 mg group
one capsule of pregabalin 150 mg and one placebo capsule
pregabalin
one capsule of pregabalin 150 mg and one placebo capsule 1 hr before surgery
pregabalin 300 mg group
two capsules of pregabalin 150 mg
pregabalin
two capsules of pregabalin 150 mg 1 hr before surgery
placebo group
to receive two identical placebo capsules
Placebo
to receive two identical placebo capsules 1 hr before surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Placebo
to receive two identical placebo capsules 1 hr before surgery
pregabalin
one capsule of pregabalin 150 mg and one placebo capsule 1 hr before surgery
pregabalin
two capsules of pregabalin 150 mg 1 hr before surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for elective laparoscopic cholecystectomy
* under sevoflurane anesthesia
Exclusion Criteria
* cardiovascular diseases
* renal diseases
* hepatic diseases
* endocrinal diseases
* neuropsychiatric diseases
* prolonged P-R interval
* pregnancy
* nursing
* hypersensitivity
* treated by pregabalin, antidepressant, anticonvulsants, opiates or benzodiazepines during the last week
25 Years
55 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mohamed R El Tahan
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University Hospitals
Al Mansurah, DK, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R/49
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.